Navigation Links
Artery Stiffness Linked To Increasing Levels Of C-reactive protein

Mayo Clinic researchers have shown that increased levels of C-reactive protein in the blood are associated with the stiffening of the arteries.

This finding could lead to new and improved // public health strategies to prevent heart disease, such as developing drugs that suppress inflammation to improve the health of arteries before full-blown heart disease develops.

The Mayo Clinic research report appears online and in the August issue of the American Journal of Hypertension.

The Mayo Clinic collaborative study with researchers from the University of Michigan looked at 214 men and women with an average age of 59, who had no history of heart attack or stroke. Results suggest that low-grade inflammation is associated with arterial stiffness (hardening). This inflammation may be a potential mechanism through which C-reactive protein is related to heart attack and stroke, and why testing for C-reactive protein in a blood test may be an effective early warning test for asymptomatic, or presymptomatic heart disease.

Researchers around the world agree that C-reactive protein is associated with increased risk of heart attack and stroke. But it remains controversial whether C-reactive protein is a risk factor that affects the function of blood vessels, or if it is simply a marker signifying the presence of disease.

In addition to taking into account the traditional risk factors for heart disease—such as male sex, presence of diabetes, high blood pressure, high cholesterol and smoking—the research team also measured C-reactive protein levels as well as three indicators of arterial stiffness. Stiffening of arteries indicates a loss of their elastic properties and predisposes to heart attack, stroke and congestive heart failure.

The current inability to accurately predict cardiovascular events such as heart attack is a problem. The researchers said that their study provides a new insight into how low grade i nflammation could be related to heart and stroke by its association with arterial stiffness. Thus suppression of inflammation may be a target of drug therapy to improve arterial health.

Source: Newswise
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. The Link Between Oxidized Phospholipids And Coronary Artery Disease
3. Stents That Release Medication To Check Artery Narrowing
4. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
5. Stenting: A Possible Remedy For Brain Artery Blockage
6. Peripheral Artery Disease Can Be Delayed By Walking
7. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
8. Physical Activity benefited Peripheral Artery Disease (PAD) patients
9. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
10. Methamphetamine Use Increases Risks of Artery Tears and Stroke
11. Early Detection of Artery Weakening Can Be a Life-Saver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the University of California Berkeley, and other leading institutions in announcing the launch ... of institutions to change the way animals are raised for food. , Founding ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: